MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The Impact of Cognitive Changes on Everyday Life for People with Parkinson’s: The Patient’s Perspective

    J. Wertheimer, A. Gottuso, A. Duboille, M. Tuchman, C. Walton (Los Angeles, CA, USA)

    Objective: To understand the patient’s perspective about cognitive changes in Parkinson’s disease and about the impact of cognitive dysfunction on daily life.   Background: Cognitive dysfunction is…
  • 2017 International Congress

    Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.

    M. Hoock, F. Maier, R. Kaur, C. Eggers, L. Timmermann (Cologne, Germany)

    Objective: To examine whether Parkinson’s disease (PD) patients with or without mild cognitive impairment (MCI) show impaired self-awareness (ISA) of their cognitive abilities. Background: PD…
  • 2017 International Congress

    Risk Factors for Dementia in Parkinson’s disease

    M.I. Khalil, M.R. Rahman, S. Munira (Dhaka, Bangladesh)

    Objective: To investigate putative risk factors for the development of dementia in patients with Parkinson’s disease. Background: Dementia in idiopathic Parkinson’s disease (PD) is a…
  • 2017 International Congress

    Ghrelin and the IGF-1 axis in cognitive impairment in PD

    F. Johnston, M. Siervo, A. Hornsby, J. Davies, D. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: To explore the association of acyl-ghrelin (AG) levels with cognitive impairment (CI) in PD Background: Unintended weight loss (UWL) in PD is associated with…
  • 2017 International Congress

    Cognitive strategy use during daily activities in people with Parkinson’s Disease

    I. Sturkenboom, E. Steultjens, M. Nott, C. Chapparo (Nijmegen, Netherlands)

    Objective: To identify difficulties in cognitive strategy use observed in people with Parkinsons’s disease (PD) during performance of everyday activities. Background: People use cognitive strategies…
  • 2017 International Congress

    Validation of Computerised Measures of Executive Functioning for use in Parkinson’s Disease Assessments.

    T. Dominey, C. Carroll, R. Noad, C. Newman, S. Hall (Plymouth, United Kingdom)

    Objective: i. To validate the use of a computerised finger tapping task as a screening measure for Executive Dysfunction (EF) in Parkinson’s Disease (PD), against…
  • 2017 International Congress

    The Cats & Dogs Test: a web-based platform to detect early visual processing deficits in Parkinson’s disease

    R. Weil, B. Bahrami, D. Schwarzkopf, I. Pavisic, K. Pappa, R. Schade, H. Morris (London, United Kingdom)

    Objective: To develop a sensitive web-based test to detect visuo-perceptual deficits in patients with Parkinson’s disease as an early marker of dementia. Background: Up to…
  • 2017 International Congress

    Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

    Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)

    Objective: To clarify clinical features of patients with progressive mild cognitive impairment patients (MCI) in Parkinson’s disease (PD-MCI). Background: Non-demented PD subjects have MCI and…
  • 2017 International Congress

    The Effects of Contingency-based Musical Gait Feedback on Cognition in Individuals with Parkinson’s disease: An Interim Analysis

    J. Burt, E. Ravid, S. Bradford, N. Fisher, Y. Zeng, B. Hu, R. Camicioli (Edmonton, AB, Canada)

    Objective: To investigate the effects of a 12-week home-based musical gait feedback program on cognition in persons with Parkinson’s disease (PD). Background: Individuals with PD…
  • 2017 International Congress

    Differential peculiarities of cognitive disorders in Parkinson’s disease dementia and Vascular dementia

    V. Mykhaylov, I. Zdesenko (Kharkiv, Ukraine)

    Objective:  To study differential peculiarities of cognitive functions disorders in Parkinson's disease (PD) dementia and vascular dementia (VD). Background: 44 VD and 18 PD dementia…
  • « Previous Page
  • 1
  • …
  • 1465
  • 1466
  • 1467
  • 1468
  • 1469
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley